Re:NewCell AB (publ)

SSE:RENEW.ST

5 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

202220212020201920182017
Revenue 13.8053.5731.4530.7500
Cost of Revenue 82.28215.857.614.40600
Gross Profit -68.477-12.277-6.157-3.65600
Gross Profit Ratio -4.96-3.436-4.237-4.87500
Reseach & Development Expenses 3.1013.1420000
General & Administrative Expenses 38.10541.45631.88118.50210.45517.525
Selling & Marketing Expenses 10.1673.990000
SG&A 48.27241.45631.88118.50210.45517.525
Other Expenses 149.674.98430.24714.9687.4132.575
Operating Expenses 197.872116.4462.12833.4717.86820.1
Operating Income -262.991-128.315-68.286-37.126-17.868-20.1
Operating Income Ratio -19.05-35.912-46.997-49.50100
Total Other Income Expenses Net -36.943-5.115-0.436-0.531-0.55-3.11
Income Before Tax -299.934-133.43-68.722-37.657-18.418-23.21
Income Before Tax Ratio -21.726-37.344-47.297-50.20900
Income Tax Expense 0.0025.5410.4590.53100
Net Income -299.936-138.971-69.181-38.188-18.418-23.21
Net Income Ratio -21.727-38.895-47.613-50.91700
EPS -8.09-4.51-3.36-1.24-0.6-0.75
EPS Diluted -8.09-4.3-3.34-1.24-0.6-0.75
EBITDA -251.154-120.231-61.306-30.073-17.849-18.661
EBITDA Ratio -18.193-33.65-42.193-40.09700